easyseptm human cd34 positive selection kit Search Results


cd34 selection kit  (Miltenyi Biotec)
99
Miltenyi Biotec cd34 selection kit
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Cd34 Selection Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd34 selection kit/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
cd34 selection kit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
easyseptm human cd34-positive selection kit  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easyseptm human cd34-positive selection kit
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Easyseptm Human Cd34 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easyseptm human cd34-positive selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easyseptm human cd34-positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-cd34 magnetic beads easyseptm human cd34 positive selection kit  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc anti-cd34 magnetic beads easyseptm human cd34 positive selection kit
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Anti Cd34 Magnetic Beads Easyseptm Human Cd34 Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd34 magnetic beads easyseptm human cd34 positive selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
anti-cd34 magnetic beads easyseptm human cd34 positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human miltenyi biotech 130 046 702 easyseptm human cd4 t cell enrichment kit stemcell technologies  (Miltenyi Biotec)
99
Miltenyi Biotec human miltenyi biotech 130 046 702 easyseptm human cd4 t cell enrichment kit stemcell technologies
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Human Miltenyi Biotech 130 046 702 Easyseptm Human Cd4 T Cell Enrichment Kit Stemcell Technologies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human miltenyi biotech 130 046 702 easyseptm human cd4 t cell enrichment kit stemcell technologies/product/Miltenyi Biotec
Average 99 stars, based on 1 article reviews
human miltenyi biotech 130 046 702 easyseptm human cd4 t cell enrichment kit stemcell technologies - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
easyseptm  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easyseptm
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Easyseptm, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easyseptm/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easyseptm - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
easyseptm human progenitor cell enrichment kit with platelet depletion  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easyseptm human progenitor cell enrichment kit with platelet depletion
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Easyseptm Human Progenitor Cell Enrichment Kit With Platelet Depletion, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easyseptm human progenitor cell enrichment kit with platelet depletion/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easyseptm human progenitor cell enrichment kit with platelet depletion - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
easyseptm human biotin positive selection kit ii  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easyseptm human biotin positive selection kit ii
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Easyseptm Human Biotin Positive Selection Kit Ii, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easyseptm human biotin positive selection kit ii/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easyseptm human biotin positive selection kit ii - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
easyseptm magnet  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easyseptm magnet
(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these <t>CD34+</t> IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow <t>CD34</t> + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).
Easyseptm Magnet, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easyseptm magnet/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easyseptm magnet - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
easyseptm release human fitc positive selection kit  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc easyseptm release human fitc positive selection kit
A Flow cytometry was used to detect CD34 + CD90 + ECs in 2 GBC tissues (PE: CD34, <t>FITC:</t> CD90). B Representative multiple immune staining images of CD34 and CD90 in GBC tissues. C Immune staining of CD34 and CD90 on GBC tissue microarray. D Analysis of the correlation between CD34 + or CD34 + CD90 + cell contents and patient survival prognosis and clinical characteristics. OS, overall survival time.
Easyseptm Release Human Fitc Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easyseptm release human fitc positive selection kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easyseptm release human fitc positive selection kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
roboseptm buffer  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc roboseptm buffer
A Flow cytometry was used to detect CD34 + CD90 + ECs in 2 GBC tissues (PE: CD34, <t>FITC:</t> CD90). B Representative multiple immune staining images of CD34 and CD90 in GBC tissues. C Immune staining of CD34 and CD90 on GBC tissue microarray. D Analysis of the correlation between CD34 + or CD34 + CD90 + cell contents and patient survival prognosis and clinical characteristics. OS, overall survival time.
Roboseptm Buffer, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roboseptm buffer/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
roboseptm buffer - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ficoll gradient  (Eurobio)
90
Eurobio ficoll gradient
A Flow cytometry was used to detect CD34 + CD90 + ECs in 2 GBC tissues (PE: CD34, <t>FITC:</t> CD90). B Representative multiple immune staining images of CD34 and CD90 in GBC tissues. C Immune staining of CD34 and CD90 on GBC tissue microarray. D Analysis of the correlation between CD34 + or CD34 + CD90 + cell contents and patient survival prognosis and clinical characteristics. OS, overall survival time.
Ficoll Gradient, supplied by Eurobio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ficoll gradient/product/Eurobio
Average 90 stars, based on 1 article reviews
ficoll gradient - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
cd34 microbead kit ultrapure  (Miltenyi Biotec)
97
Miltenyi Biotec cd34 microbead kit ultrapure
A Flow cytometry was used to detect CD34 + CD90 + ECs in 2 GBC tissues (PE: CD34, <t>FITC:</t> CD90). B Representative multiple immune staining images of CD34 and CD90 in GBC tissues. C Immune staining of CD34 and CD90 on GBC tissue microarray. D Analysis of the correlation between CD34 + or CD34 + CD90 + cell contents and patient survival prognosis and clinical characteristics. OS, overall survival time.
Cd34 Microbead Kit Ultrapure, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd34 microbead kit ultrapure/product/Miltenyi Biotec
Average 97 stars, based on 1 article reviews
cd34 microbead kit ultrapure - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

Image Search Results


(A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these CD34+ IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow CD34 + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).

Journal: PLoS ONE

Article Title: Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR

doi: 10.1371/journal.pone.0140372

Figure Lengend Snippet: (A) and (B) were isotype controls for the detection. (C) The expression of IGF-IR on CD134+ cells from 1 normal control was 4.3%. (D) Of these CD34+ IGF-IR+ cells, 75.3% expressed the erythroid lineage marker CD235a. (E) The expression of IGF-IR on bone marrow CD34 + cells was 82.9% in 1 MDS patient. (F) IGF-IR was expressed on the surface of 15.8% erythroid lineage cells from the same MDS patient. There was not significant expression of IGF-IR on the T lymphocytes (G) or B lymphocytes (H) from the same MDS patient. (I) The expression of IGF-IR of CD34 + cells from the 55 MDS patients was significantly higher than that of cells from the normal controls (54.0 vs. 4.5%; P <0.0001). (J) The expression of IGF-IR of CD34 + cells in the abnormal chromosome group was significantly higher than that in the normal chromosome group (72.0 vs. 50.4%; P = 0.019).

Article Snippet: CD34 + cells from 1×10 7 isolated mononuclear cells were sorted using a CD34 + selection kit (EasySepTM Human CD34 Positive Selection Kit, 18056, Miltenyi Biotec, Germany) according to the instruction manual provided by Miltenyi Biotec.

Techniques: Expressing, Control, Marker

After CD34 + cells from 6 MDS patients were amplified in vitro , PPP was added at a concentration of 1 μM, and DMSO was used as a control. Cells at 0, 24, 48, 72, 96, and 168 h (7 d) after drug treatment were collected to calculate the mortality by Trypan Blue staining and smeared onto slides to detect the percentage of clonal cells using FISH. Over time, (A) the percentage of clonal cells progressively decreased. The P value resulted from the comparison between before PPP drug intervention (0 h) and 168 h (7 d) after intervention. The average percentage decreased from the initial 80.7 to 60.0%, and the difference was statistically significant. (B) The cell mortality increased over time and the difference from the control was statistically significant.

Journal: PLoS ONE

Article Title: Purification of Bone Marrow Clonal Cells from Patients with Myelodysplastic Syndrome via IGF-IR

doi: 10.1371/journal.pone.0140372

Figure Lengend Snippet: After CD34 + cells from 6 MDS patients were amplified in vitro , PPP was added at a concentration of 1 μM, and DMSO was used as a control. Cells at 0, 24, 48, 72, 96, and 168 h (7 d) after drug treatment were collected to calculate the mortality by Trypan Blue staining and smeared onto slides to detect the percentage of clonal cells using FISH. Over time, (A) the percentage of clonal cells progressively decreased. The P value resulted from the comparison between before PPP drug intervention (0 h) and 168 h (7 d) after intervention. The average percentage decreased from the initial 80.7 to 60.0%, and the difference was statistically significant. (B) The cell mortality increased over time and the difference from the control was statistically significant.

Article Snippet: CD34 + cells from 1×10 7 isolated mononuclear cells were sorted using a CD34 + selection kit (EasySepTM Human CD34 Positive Selection Kit, 18056, Miltenyi Biotec, Germany) according to the instruction manual provided by Miltenyi Biotec.

Techniques: Amplification, In Vitro, Concentration Assay, Control, Staining, Comparison

A Flow cytometry was used to detect CD34 + CD90 + ECs in 2 GBC tissues (PE: CD34, FITC: CD90). B Representative multiple immune staining images of CD34 and CD90 in GBC tissues. C Immune staining of CD34 and CD90 on GBC tissue microarray. D Analysis of the correlation between CD34 + or CD34 + CD90 + cell contents and patient survival prognosis and clinical characteristics. OS, overall survival time.

Journal: NPJ Precision Oncology

Article Title: Single-cell analysis reveals CD34 + CD90 + endothelial cells promote tumor metastasis in gallbladder cancer

doi: 10.1038/s41698-025-01040-2

Figure Lengend Snippet: A Flow cytometry was used to detect CD34 + CD90 + ECs in 2 GBC tissues (PE: CD34, FITC: CD90). B Representative multiple immune staining images of CD34 and CD90 in GBC tissues. C Immune staining of CD34 and CD90 on GBC tissue microarray. D Analysis of the correlation between CD34 + or CD34 + CD90 + cell contents and patient survival prognosis and clinical characteristics. OS, overall survival time.

Article Snippet: Subsequently, FITC-conjugated CD90 antibody was added to the sorted CD34 + endothelial cells, and an EasySepTM Release Human FITC Positive Selection Kit (STEMCELL Technologies) was used to isolate CD34 + CD90 + endothelial cells.

Techniques: Flow Cytometry, Staining, Microarray